Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEMIS.L Regulatory News (EMIS)

  • There is currently no data for EMIS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Purchase of outstanding stake in Rx Systems

1 Nov 2018 07:00

RNS Number : 9518F
EMIS Group PLC
01 November 2018
 

01 November 2018

EMIS Group plc

("EMIS Group" or "the Group")

Purchase of outstanding minority stake in Rx Systems Limited ("Rx")

EMIS Group is pleased to announce that it has acquired the outstanding minority stake in its subsidiary Rx, which trades as EMIS Health Community Pharmacy, giving the Group 100% control of the business.

The 21.1% minority stake was acquired from Phoenix Medical Supplies Limited ("Phoenix"), the leading pharmaceutical wholesaler, which has held its stake since before EMIS Group acquired 78.9% of Rx in 2010. Phoenix, which owns more than 500 pharmacies in the UK, is a significant user of Rx's systems and services, and is expected to remain an important customer of the Group going forward.

The consideration for the purchase is £8.0 million in cash, which has been funded out of EMIS Group's existing cash reserves. Prior to completion, Rx paid a dividend to its shareholders of £19.0 million from its accumulated reserves, of which £4.0 million was paid to Phoenix with the balance retained within the Group.

For the year ended 31 December 2017, Rx contributed revenues of £21.9 million and a segmental operating profit of £5.6 million to the Group. The transaction is expected to be immediately earnings enhancing for EMIS Group.

Commenting on the purchase, EMIS Group CEO Andy Thorburn said:

"Rx has been an important contributor to EMIS Group since 2010 and Phoenix a valued partner, co-investor and customer throughout that period. We are pleased to have come to this agreement and to consolidate full control of Rx which, as the market-leading community pharmacy solution, remains central to the Group's strategy of providing connected healthcare software and services across every major UK healthcare setting."

- ENDS -

Enquiries:

For further information, contact:

 

EMIS Group plc Tel: 0113 380 3000

Andy Thorburn, CEO

Peter Southby, CFO

www.emisgroupplc.com

@EMISGroup

 

Numis Securities Limited (Nominated Adviser & Broker) Tel: 020 7260 1000

Oliver Hardy/Simon Willis/James Black

 

MHP Communications Tel: 020 3128 8572

Reg Hoare/Giles Robinson/Patrick Hanrahan/Florence Mayo

emis@mhpc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQGMMFGMMGGRZZ
Date   Source Headline
30th Oct 20237:00 amRNSCancellation - EMIS Group PLC
27th Oct 20234:57 pmRNSForm 8.3 - EMIS LN
27th Oct 20233:30 pmGNWForm 8.3 - EMIS Group plc
27th Oct 20233:20 pmRNSForm 8.3 - EMIS Group plc
27th Oct 20232:52 pmRNSHolding(s) in Company
27th Oct 20231:45 pmPRNForm 8.3 - EMIS Group Plc
27th Oct 202312:53 pmRNSForm 8.3 - EMIS GROUP PLC
27th Oct 202311:17 amRNSForm 8.3 - EMIS Group PLC
27th Oct 202311:07 amRNSForm 8.3 - EMIS Group Plc
27th Oct 202310:59 amRNSForm 8.3 - EMIS Group plc
27th Oct 202310:06 amRNSForm 8.3 - EMIS Group plc
27th Oct 20239:22 amRNSForm 8.5 (EPT/RI) - EMIS Group Plc
27th Oct 20239:03 amRNSForm 8.3 - EMIS Group Plc
27th Oct 20238:55 amGNWForm 8.3 - [EMIS GROUP PLC 26 10 2023] - (CGWL)
27th Oct 20237:30 amRNSSuspension - EMIS Group PLC
27th Oct 20237:00 amRNSScheme of arrangement becomes effective
26th Oct 20235:28 pmRNSHolding(s) in Company
26th Oct 20233:52 pmRNSHolding(s) in Company
26th Oct 20233:30 pmRNSForm 8.3 - EMIS LN
26th Oct 20233:30 pmGNWForm 8.3 - EMIS Group plc
26th Oct 20233:29 pmRNSForm 8.3 - Emis Group plc
26th Oct 20233:20 pmRNSForm 8.3 - EMIS Group plc
26th Oct 20232:33 pmRNSForm 8.3 - EMIS Group Plc
26th Oct 20232:09 pmPRNForm 8.3 - EMIS Group plc
26th Oct 20232:08 pmRNSForm 8.3 - EMIS Group Plc
26th Oct 20231:54 pmRNSForm 8.3 - EMIS Group plc
26th Oct 202310:26 amRNSForm 8.3 - Emis Group plc
26th Oct 20239:19 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - EMIS GROUP PLC - Ordinary Shares
25th Oct 20233:58 pmRNSForm 8 (DD) - EMIS Group plc
25th Oct 20233:57 pmRNSForm 8 (DD) - EMIS Group plc
25th Oct 20233:54 pmRNSDirector/PDMR Shareholding
25th Oct 20233:52 pmRNSCourt sanction of scheme of arrangement
25th Oct 20233:29 pmRNSForm 8.3 - EMIS Group PLC
25th Oct 20233:20 pmRNSForm 8.3 - EMIS Group plc
25th Oct 20232:39 pmPRNForm 8.3 - EMIS Group plc
25th Oct 20232:09 pmRNSForm 8.3 - EMIS Group plc
25th Oct 202310:49 amGNWForm 8.3 - [EMIS GROUP PLC 24 10 2023] - (CGWL)
25th Oct 202310:35 amRNSForm 8.3 - 20231024_EMIS Group plc_8.3_UK_BAC
25th Oct 202310:32 amRNSDirector/PDMR Shareholding
25th Oct 202310:27 amRNSForm 8 (DD) - EMIS Group plc
25th Oct 20239:40 amRNSForm 8.5 (EPT/RI) - EMIS Group Plc
24th Oct 20233:20 pmRNSForm 8.3 - EMIS Group plc
24th Oct 20231:47 pmRNSForm 8 (DD) - EMIS Group plc
24th Oct 20231:45 pmRNSForm 8 (DD) - EMIS Group plc
24th Oct 20231:44 pmPRNForm 8.3 - EMIS Group plc
24th Oct 20231:42 pmRNSDirector/PDMR Shareholding
24th Oct 202312:26 pmRNSForm 8.3 - EMIS Group plc
24th Oct 202310:09 amRNSHolding(s) in Company
24th Oct 202310:07 amRNSHolding(s) in Company
24th Oct 202310:03 amRNSAdmission of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.